On January 29, 2023, on the eighth day of the first lunar month, Lai Wensheng, deputy secretary of the Party Working Committee and deputy director of the Management Committee of Torch Development Zone, Huang Shuyan, deputy director of the District Economic Science Bureau, and Yu Conghong, deputy general manager of National Health Base Group Co., Ltd. visited Shenzhen Cell Valley Biomedicine Co., LTD., the parent company of Junhou Biology. Shenzhen Cell Valley and Junhou Biology chairman Shi Yuanyuan, chairman assistant Wei Zheng, general office director Luan Zhishi warm reception.

   
At the symposium, Chairman Shi Yuanyuan introduced the industrial layout, development concept and future planning of Junhou Biology and Shenzhen Cell Valley; At the same time, it also describes the development of Shenzhen's major industries and Shenzhen. 20 + 8 & # 8221; The key industrial development planning of industrial clusters and the core competitiveness of Shenzhen's differentiated development in the field of biomedicine. Shi Yuan expressed his gratitude and recognition to Zhongshan City and Torch Development Zone for a series of measures in planning the urban development strategy and deepening the reform of the business environment, and thanked the Zhongshan City and Torch District government for their efficient and selfless service and determination to work together with enterprises to seek common development. Lai Wensheng, deputy secretary of the Party Working Committee and deputy director of the Management Committee of the Torch Development Zone, also explained that the Torch Development Zone will promote the implementation of high-quality projects through location advantages, basic supporting facilities, service system and policy resources, and focus on the interaction of the cell therapy industry in Shenzhen and Zhongshan, build open and cooperative government-enterprise communication channels, and support the construction of Junhou Biology. To realize the effective layout of the whole industrial chain from scientific research to production to clinical, and jointly promote the high-quality development of cell and gene therapy industry in South China.